NYSEARCA:REVS Columbia Research Enhanced Value ETF (REVS) Price, Holdings, & News $34.13 +0.13 (+0.38%) As of 12:17 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock About Columbia Research Enhanced Value ETF (NYSEARCA:REVS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get REVS alerts:Sign Up Key Stats Today's Range$34.02▼$34.1350-Day Range$31.21▼$34.0052-Week Range$27.15▼$34.13Volume3,892 shsAverage Volume53,221 shsMarket Capitalization$341.30 millionAssets Under Management$347.85 millionDividend YieldN/ANet Expense Ratio0.19%Aggregate RatingModerate Buy ETF Overview The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia. Read More Columbia Research Enhanced Value ETF ExpensesTypeREVSLarge Cap ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.19%0.58%0.57%0.51%0.53%Other Expenses0.01%0.28%0.53%0.60%0.54%Total Expense0.20%0.64%0.75%0.75%0.73%Fee Waiver-0.01%-0.27%-0.67%-0.77%-0.68%Net Expense0.19%0.61%0.63%0.57%0.60% Receive REVS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Columbia Research Enhanced Value ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. REVS ETF News HeadlinesColumbia Research Enhanced International Equity ETFJune 10, 2026 | barrons.comColumbia Research Enhanced Real Estate ETF declares quarterly distribution of $0.6354December 19, 2025 | msn.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.August 14 at 1:00 AM | Banyan Hill Publishing (Ad)Fidelity Enhanced Large Cap Value ETF declares quarterly distribution of $0.1460September 29, 2025 | msn.comColumbia Research Enhanced Core ETF (ARCA:RECS), Top HoldingsJuly 8, 2025 | benzinga.comInvesting With Training Wheels: How Buffer ETFs Can Help Mitigate RiskMarch 2, 2025 | theglobeandmail.comSee More Headlines REVS ETF - Frequently Asked Questions How have REVS shares performed this year? Columbia Research Enhanced Value ETF's stock was trading at $28.28 at the beginning of the year. Since then, REVS stock has increased by 20.5% and is now trading at $34.08. How do I buy shares of Columbia Research Enhanced Value ETF? Shares of REVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Columbia Research Enhanced Value ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Columbia Research Enhanced Value ETF investors own include Geo Group (GEO), Global X SuperDividend REIT ETF (SRET), British American Tobacco (BTI), Energy Transfer (ET), International Business Machines (IBM) and Annaly Capital Management (NLY). Fund Details IssuerColumbia Fund NameColumbia Research Enhanced Value ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:REVS Inception Date9/25/2019 Fund ManagerChristopher Lo, Jason Wang, Henry Hom WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkBeta Advantage Research Enhanced U.S. Value Index CategorySize and Style FocusLarge Cap Development LevelDeveloped Markets RegionNorth America Number of Holdings306 Fund Statistics Assets Under Management$347.85 million Average Daily Volume$0.00 Discount/Premium0.02% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorColumbia Management Investment Advisers, LLC CustodianState Street Bank and Trust Company DistributorALPS Distributors, Inc. Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerJane Street Options OptionableN/A Short Interest27,888 shs Miscellaneous Outstanding Shares10,000,000Beta0.79 Creation Unit25,000 Creation Fee$500.00 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report Top 10 REVS HoldingsApple (NASDAQ:AAPL)Holding Weight: 7.96%Microsoft (NASDAQ:MSFT)Holding Weight: 7.07%Bank of America (NYSE:BAC)Holding Weight: 3.89%Chevron (NYSE:CVX)Holding Weight: 2.55%Altria Group (NYSE:MO)Holding Weight: 2.20%Citigroup (NYSE:C)Holding Weight: 1.95%Meta Platforms (NASDAQ:META)Holding Weight: 1.87%Cisco Systems (NASDAQ:CSCO)Holding Weight: 1.76%TJX Companies (NYSE:TJX)Holding Weight: 1.74%Bristol Myers Squibb (NYSE:BMY)Holding Weight: 1.72%Full Holdings DetailsREVS Sector ExposureREVS Industry Exposure This page (NYSEARCA:REVS) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersBSEM Is Officially on Nasdaq... The Next Chapter Begins!BioStem Technologies (NASDAQ: BSEM) debuted on Nasdaq August 7th, marking its move from OTC markets into a new...Huge Alerts | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredWall Street is staring at the wrong AI tradeAnthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...The Oxford Club | SponsoredAfter KDA, PRE, and OCEAN—this is the one17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Columbia Research Enhanced Value ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Columbia Research Enhanced Value ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free REVS Stock Alerts